![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Open AccessEmerging echinocandin-resistant Candida albicans and glabrata in Switzerland
Echinocandins represent the first-line therapy of candidemia. Echinocandin resistance among Candida spp. is mainly due to acquired FKS mutations. In this study, we report the emergence of FKS-mutant Candida albic...
-
Article
Treatment and outcomes of Candida osteomyelitis: review of 53 cases from the PATH Alliance® registry
Candida osteomyelitis is associated with significant morbidity; however, data on the management of Candida osteomyelitis are limited. The Prospective Antifungal Therapy (PATH) Alliance® registry ...
-
Article
Use of the PATH Alliance database to measure adherence to IDSA guidelines for the therapy of candidemia
Candidemia is an increasing complication of the care of complex patients. Adherence to Infectious Diseases Society of America (IDSA) guidelines for the treatment of candidemia was investigated to assess the im...